Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Gross Profit (2020 - 2025)

RxSight's Gross Profit history spans 6 years, with the latest figure at $25.3 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 12.24% year-over-year to $25.3 million; the TTM value through Dec 2025 reached $103.0 million, up 4.11%, while the annual FY2025 figure was $103.0 million, 4.11% up from the prior year.
  • Gross Profit reached $25.3 million in Q4 2025 per RXST's latest filing, up from $24.2 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $28.8 million in Q4 2024 to a low of -$812000.0 in Q2 2021.
  • Average Gross Profit over 5 years is $14.1 million, with a median of $12.9 million recorded in 2023.
  • Peak YoY movement for Gross Profit: plummeted 71.31% in 2021, then soared 689.66% in 2022.
  • A 5-year view of Gross Profit shows it stood at $2.9 million in 2021, then surged by 158.7% to $7.4 million in 2022, then soared by 137.86% to $17.7 million in 2023, then skyrocketed by 63.07% to $28.8 million in 2024, then fell by 12.24% to $25.3 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Gross Profit are $25.3 million (Q4 2025), $24.2 million (Q3 2025), and $25.2 million (Q2 2025).